The follow-up of the «Changes of Special Interest in already Authorized Medicines» through the notes provided by regulatory agencies is crucial to ensure the safe and effective use of existing medicines. These updates, which address modifications in posology and other key sections, allow healthcare professionals to keep up to date with the latest recommendations and guidance on the appropriate use of medicines.
In addition, they provide the opportunity to adjust and personalize treatments, thus maximizing therapeutic benefits and minimizing potential risks to patients' health. Keeping abreast of these changes is essential to maintain high standards of safety and efficacy in medical care, promoting more precise care tailored to the individual needs of each patient.
By providing timely and detailed access to these significant changes, we make it easier for healthcare professionals to make informed updates to treatment management, ensuring that patients receive the most appropriate and safe care possible. This proactive approach to changes in already approved medicines contributes to evidence-based clinical practice and improves the quality of care provided to patients.
EN 
ES